Success Metrics

Clinical Success Rate
93.3%

Based on 14 completed trials

Completion Rate
93%(14/15)
Active Trials
1(5%)
Results Posted
36%(5 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
2
10%
Ph phase_1
1
5%
Ph phase_3
6
30%
Ph phase_4
4
20%
Ph not_applicable
3
15%

Phase Distribution

1

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
1(6.3%)
Phase 2Efficacy & side effects
2(12.5%)
Phase 3Large-scale testing
6(37.5%)
Phase 4Post-market surveillance
4(25.0%)
N/ANon-phased studies
3(18.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.3%

14 of 15 finished

Non-Completion Rate

6.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

20

all time

Status Distribution
Active(1)
Completed(14)
Terminated(1)
Other(4)

Detailed Status

Completed14
unknown4
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
1
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.3%)
Phase 22 (12.5%)
Phase 36 (37.5%)
Phase 44 (25.0%)
N/A3 (18.8%)

Trials by Status

recruiting15%
completed1470%
terminated15%
unknown420%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT05149560Phase 2

Ticagrelor Monotherapy After Stenting

Completed
NCT04007055Phase 3

The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

Terminated
NCT05476991Phase 3

Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

Recruiting
NCT02016170Not Applicable

Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor

Completed
NCT04255602Phase 4

A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

Unknown
NCT04057300Phase 4

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes

Completed
NCT04738097Phase 3

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

Completed
NCT04237935

Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data

Completed
NCT05086081

Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data

Completed
NCT04718025Phase 3

Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

Unknown
NCT04766437Phase 2

Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy

Completed
NCT03649711Phase 3

Chronic Kidney Disease (CKD) Platelet Study

Completed
NCT04739384Phase 3

Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS

Completed
NCT04001894Phase 4

Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease

Completed
NCT04267224

Early Versus Late Loading of Ticagrelol in Patients With STEMI

Unknown
NCT04060914Phase 4

LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Unknown
NCT03613857

Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)

Completed
NCT03441412Phase 1

A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With Ticagrelor

Completed
NCT02081443Not Applicable

In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients

Completed
NCT01731041Not Applicable

Impact of Ticagrelor Re-load on Pharmacodynamic Profiles

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20